TI
ALNY icon

Tidal Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Tidal Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Sell
33,541
-24,386
-42% -$7.36M 0.02% 690
2026
Q1 		$18.8M Buy
57,927
+53,102
+1,101% +$18.1M 0.04% 377
2025
Q4 		$1.92M Sell
4,825
-2,066
-30% -$914K ﹤0.01% 968
2025
Q3 		$3.14M Buy
6,891
+1,317
+24% +$536K 0.01% 722
2025
Q2 		$1.82M Sell
5,574
-553
-9% -$153K 0.01% 776
2025
Q1 		$1.65M Sell
6,127
-7,061
-54% -$1.81M 0.01% 774
2024
Q4 		$3.1M Sell
13,188
-7,356
-36% -$1.93M 0.02% 526
2024
Q3 		$5.65M Buy
20,544
+8,811
+75% +$2.29M 0.06% 300
2024
Q2 		$2.85M Buy
11,733
+1,452
+14% +$229K 0.04% 414
2024
Q1 		$1.54M Buy
10,281
+7,660
+292% +$1.28M 0.03% 661
2023
Q4 		$502K Buy
2,621
+344
+15% +$58.6K 0.01% 937
2023
Q3 		$403K Buy
2,277
+56
+3% +$10.7K 0.01% 943
2023
Q2 		$422K Sell
2,221
-1,574
-41% -$312K 0.01% 903
2023
Q1 		$760K Sell
3,795
-473
-11% -$99.4K 0.03% 592
2022
Q4 		$1.01M Buy
4,268
+1,827
+75% +$390K 0.04% 442
2022
Q3 		$489K Buy
2,441
+633
+35% +$121K 0.02% 574
2022
Q2 		$264K Sell
1,808
-595
-25% -$84.4K 0.01% 829
2022
Q1 		$392K Buy
2,403
+222
+10% +$33.8K 0.01% 733
2021
Q4 		$370K Sell
2,181
-193
-8% -$35.9K 0.01% 705
2021
Q3 		$448K Buy
2,374
+373
+19% +$70K 0.02% 540
2021
Q2 		$339K Buy
+2,001
New +$293K 0.01% 534

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tidal Investments's ALNY Position: Q2 2026 in Review

Tidal Investments reduced its Alnylam Pharmaceuticals (ALNY) stake by 42% in Q2 2026, selling an estimated $7.36M and leaving 33,541 shares worth $10.1M. The position accounts for 0.02% of the portfolio, ranked #690.

Tidal Investments first reported a position in ALNY in Q2 2021 and has held it in 21 quarters since. The position peaked at $18.8M in Q1 2026. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Tidal Investments held 33,541 shares of Alnylam Pharmaceuticals worth $10.1M as of Q2 2026.
  • Tidal Investments sold 24,386 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $7.36M.
  • Alnylam Pharmaceuticals made up 0.02% of Tidal Investments's portfolio in Q2 2026, its #690 holding.
  • Tidal Investments first reported a position in Alnylam Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Tidal Investments's Alnylam Pharmaceuticals position peaked at $18.8M in Q1 2026.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.